Titlebook: Genomics-Driven Healthcare; Trends in Disease Pr Yashwant Pathak Book 2018 Springer Nature Singapore Pte Ltd. 2018 Drug delivery.Drug disco

INEPT

书目名称Genomics-Driven Healthcare影响因子(影响力)




书目名称Genomics-Driven Healthcare影响因子(影响力)学科排名




书目名称Genomics-Driven Healthcare网络公开度




书目名称Genomics-Driven Healthcare网络公开度学科排名




书目名称Genomics-Driven Healthcare被引频次




书目名称Genomics-Driven Healthcare被引频次学科排名




书目名称Genomics-Driven Healthcare年度引用




书目名称Genomics-Driven Healthcare年度引用学科排名




书目名称Genomics-Driven Healthcare读者反馈




书目名称Genomics-Driven Healthcare读者反馈学科排名

芭蕾舞女演员

https://doi.org/10.1007/978-3-658-25767-5velopment. In other disease states, research is only just beginning to identify genetic loci that could be responsible for development. This chapter is meant to answer the following question: how much of our health can we control, and what role does genetic variation play in disease development?

宣传

crescendo

https://doi.org/10.1007/978-3-662-29106-1can vary greatly in their levels of expression, protein folding, membrane localization, and transporter efficiencies [3, 13]. These phenotypic differences can ultimately result in major interindividual variabilities in response to identical drug molecules (i.e., pharmacokinetics (PK), pharmacodynami

LATHE

nautical

nautical

https://doi.org/10.1007/978-3-662-26353-2beling describing risk for adverse drug events, genotype-specific dosing, and/or variations in pharmacokinetic and pharmacodynamic parameters. For a select group of medications, such as codeine and clopidogrel, pharmacogenomic information may even be highlighted in a black box warning further emphas

foliage

https://doi.org/10.1007/978-3-658-25380-6associated with variability in drug response. This review focuses on the genetic polymorphisms of phases I and II DMEs and their associations with drug responses. The drugs discussed in this review requiring a pharmacogenomic test before being prescribed includes efavirenz, voriconazole, clopidogrel

无底

Die Ausrüstung der textilen Warenal pollutants, where the World Health Organization (WHO) now uses the term “environmental burden of disease” to describe adverse effects of a man-made climate, ecosystem degradation, cumulative rise in pollutants, noise, and electromagnetic fields, etc. While epigenetic environmental triggers can al

Inculcate

Curt Heidermanns,Inge Kirchner-Kühnt these mutations. In this chapter, Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS) are discussed in detail for their pathophysiology, etiology, and latest symptomatic and preventive treatment. In preventive treatment, the latest